Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pay-for-performance
Pharma
Amgen snags another Enbrel outcomes-based payment deal
Amgen signed a deal with PBM Abarca that ties reimbursement for its RA blockbuster Enbrel to patients' willingness to stick with the drug.
Arlene Weintraub
Dec 4, 2019 10:58am
Pfizer 'brainstorming' with payers on gene therapy payment: exec
Nov 8, 2019 10:53am
Boehringer enters Jardiance outcomes-based deal with Prime
Feb 1, 2018 12:07pm
Novartis investors balk at plans to delay Alcon exit
Oct 24, 2017 10:11am
Novartis eyes markets new to performance-based pricing
Oct 5, 2017 12:14pm
Pharma execs wary of value-based contracting: PwC
Sep 22, 2017 10:30am
